Drug Profile
Clopidogrel companion diagnostic assay - McCormack Pharma
Latest Information Update: 28 Dec 2018
Price :
$50
*
At a glance
- Originator McCormack Pharma
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acute coronary syndromes
Most Recent Events
- 28 Dec 2018 No recent reports of development identified for research development in Acute coronary syndromes(Diagnosis) in United Kingdom
- 03 Nov 2014 Early research in Acute coronary syndromes (Diagnosis) in United Kingdom (unspecified route)